Polymorphism of Fcγ RIIa May Affect the Efficacy of γ-Globulin Therapy in Kawasaki Disease
暂无分享,去创建一个
Y. Komiyama | S. Taniuchi | Hakuo Takahashi | Yohnosuke Kobayashi | Yohnosuke Kobayashi | Shoichiro Taniuchi | Midori Masuda | Masayuki Teraguchi | Yumiko Ikemoto | Yutaka Komiyama | Hakuo Takahashi | Minoru Kino | M. Kino | M. Masuda | Y. Ikemoto | M. Teraguchi
[1] T. Fujisawa,et al. Studies of Peripheral Blood Toxic Neutrophils as a Predictor of Coronary Risk in Kawasaki Disease—the Pathogenetic Role of Hematopoietic Colony‐Stimulating Factors (GM‐CSF, G‐CSF) , 1990, Acta paediatrica Japonica : Overseas edition.
[2] I. Sekine,et al. Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease. , 2002, Clinical immunology.
[3] M. Poncz,et al. Rapid detection of the ligand-binding polymorphism using an allele-specific restriction enzyme digestion (ASRED) , 1996 .
[4] R. Feldman,et al. Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils , 1995, Infection and immunity.
[5] K. Harada. Intravenous γ‐Globulin Treatment in Kawasaki Disease , 1991 .
[6] H. Nakano,et al. Intravenous γ‐Globulin for Kawasaki Disease , 1991 .
[7] A. Bisno,et al. Diagnostic guidelines for Kawasaki disease. , 2001, Circulation.
[8] G. Cooper,et al. A Novel Polymorphic CAAT/Enhancer-Binding Protein β Element in the FasL Gene Promoter Alters Fas Ligand Expression: A Candidate Background Gene in African American Systemic Lupus Erythematosus Patients1 , 2003, The Journal of Immunology.
[9] H. Nakano,et al. HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR KAWASAKI DISEASE , 1983, The Lancet.
[10] M Takahashi,et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. , 1991, The New England journal of medicine.
[11] M. Ishii,et al. Plasma exchange in Kawasaki disease , 1995, The Lancet.
[12] Dirk Roos,et al. The Fc gamma RIIIA-158F allele is a risk factor for systemic lupus erythematosus , 1998 .
[13] M. Mori,et al. Predictors of coronary artery lesions after intravenous γ-globulin treatment in Kawasaki disease , 2000 .
[14] M. de Haas. IgG-Fc receptors and the clinical relevance of their polymorphisms. , 2001, Wiener klinische Wochenschrift.
[15] M. Dehaas. IgG-Fc receptors and the clinical relevance of their polymorphisms , 2001 .
[16] Wen-Chuan Lee,et al. A Swine Model of Horse Serum-Induced Coronary Vasculitis: An Implication for Kawasaki Disease , 2004, Pediatric Research.
[17] Kei Takahashi,et al. Kawasaki Disease With Particular Emphasis on Arterial Lesions , 1991, Acta pathologica japonica.
[18] D. Roos,et al. FcγRIIIa-158V/F Polymorphism Influences the Binding of IgG by Natural Killer Cell FcγRIIIa, Independently of the FcγRIIIa-48L/R/H Phenotype , 1997 .
[19] J. Newburger,et al. A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group. , 1998, The American journal of cardiology.
[20] T. Huizinga,et al. Biallelic neutrophil Na-antigen system is associated with a polymorphism on the phospho-inositol-linked Fc gamma receptor III (CD16). , 1990, Blood.